1. 1. Andrade J, Khairy P, Dobrev D, Nattel S. The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circ Res 2014; 114: 1453-68. (Review).
2. 2. Dzeshka MS, Lip GY, Snezhitskiy V, Shantsila E. Cardiac fibrosis in patients with atrial fibrillation: mechanisms and clinical implications. J Am Coll Cardiol 2015; 66: 943-59. (Review).
3. 3. Bartunek J, Delrue L, Van Durme F, et al. Nonmyocardial production of ST2 protein in human hypertrophy and failure is related to diastolic load. J Am Coll Cardiol 2008; 52: 2166-74.
4. 4. Xu SD, Su GH, Lu YX, et al. Elevated soluble ST2 and depression increased the risk of all-cause mortality and hospitalization in patients with heart failure. Int Heart J 2014; 55: 445-50.
5. 5. Minamisawa M, Motoki H, Izawa A, et al. Comparison of inflammatory biomarkers in outpatients with prior myocardial infarction. Int Heart J 2016; 57: 11-7.